Please login to read the full article.
Scrip Regulatory Affairs
Kenya issues guidance on advertisement and promotion of drugs, medical devices
01 February 2012
Vibha Sharma
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- Device, drug makers ask US FDA to clarify off-label policy
- Commission consults on unique identifiers mandated by EU falsified medicines law
- Australia amends IP framework to free access to patented inventions for regulatory approvals and research
- IFPMA revamps code of conduct to "do the right thing" in industry
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
